Read + Share
Rummel MJ, Janssens A, MacDonald D, Keating MM, et al. A phase 3, randomized study of ofatumumab combined with bendamustine in
rituximab-refractory iNHL (COMPLEMENT A + B study). Br J Haematol 2021;193:1123-1133.
PMID: 33973233
|
 |
|
Rummel MJ, Janssens A, MacDonald D, Keating MM, et al. A phase 3, randomized study of ofatumumab combined with bendamustine in
rituximab-refractory iNHL (COMPLEMENT A + B study). Br J Haematol 2021;193:1123-1133.
PMID: 33973233
|
|
|
|